Allurion Technologies Inc. (NYSE:ALUR), a leader in innovative weight loss solutions, is set to resume patient treatments in ...

NATICK, Mass., May 29, 2025--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a pioneer in metabolically healthy weight loss, today announced that Dr. Shantanu Gaur ...

Allurion Technologies Inc. (NYSE:ALUR) Q1 2025 Earnings Call Transcript May 14, 2025 Allurion Technologies Inc. beats earnings expectations. Reported EPS is $0.43, expectations were $-1.53.

Based on the one-year price targets offered by 4 analysts, the average target price for Allurion Technologies Inc (NYSE:ALUR) is $25.63 with a high estimate of $62.50 and a low estimate of $6.00.

Good morning, and thank you all for joining us. Earlier today, Allurion Technologies Inc. issued a press release announcing financial results for the quarter ended December 31st, 2024 and provided ...

Allurion Technologies Inc. (NYSE:ALUR – Get Free Report) was the recipient of a large decline in short interest during the month of April.As of April 15th, there was short interest totalling ...

NATICK, Mass.--(BUSINESS WIRE)-- Allurion Technologies, Inc. (NYSE: ALUR) (“Allurion” or the “Company”), a company dedicated to ending obesity, today ...

Virtual Care Suite (VCS) is now available to license in the United States for providers offering GLP-1 and other anti-obesity ...

You may begin. Good morning and thank you for joining us. Earlier today, Allurion Technologies Inc. issued a press release announcing financial results for the quarter ended March 31st ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...